Skip to content

Evaluation of safety and tolerability of HASG-072009 Capsules in healthy people

ââ?¬Å?An Open-Label, Single-Arm Clinical Study to evaluate the Safety and Tolerability of HASG-072009 Capsules in Healthy Adults".

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043369
Enrollment
12
Registered
2022-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Himalaya Wellness Company
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Healthy adult subjects of either sex aged between � 18 to � 50 years. 2. Subjects willing to sign informed consent and follow the study procedure. 3. Has not participated in a similar investigation in the past four weeks. 4. Subjects willing to refrain taking any other similar supplements during the study period

Exclusion criteria

Exclusion criteria: 1.Subjects with clinically significant serious cardiovascular, cerebrovascular, respiratory, hepatic, renal disease, congenital or any other disorder. 2.Subject with abnormal lab values detected at the time of screening shall be excluded. 3.A known history or present condition of allergic response to pharmaceutical products its components or ingredients in the investigational product. 4.Pre-existing systemic disease necessitating long-term medications. 5.Genetic and endocrinal disorders. 6.Subjects who refused to sign informed consent. 7.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
Occurrence of any adverse or serious adverse events during the study period.Timepoint: 7 days

Secondary

MeasureTime frame
overall compliance of study medicationTimepoint: 7 days

Countries

India

Contacts

Public ContactKavitha R

Himalaya Wellness Company

dr.srikrishna@himalayawellness.com08067547230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026